406 related articles for article (PubMed ID: 20700784)
1. [Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].
Alexiou C; Tietze R; Schreiber E; Lyer S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):839-45. PubMed ID: 20700784
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles for cancer therapy using magnetic forces.
Tietze R; Lyer S; Dürr S; Alexiou C
Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
[TBL] [Abstract][Full Text] [Related]
3. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.
Frazier N; Ghandehari H
Biotechnol Bioeng; 2015 Oct; 112(10):1967-83. PubMed ID: 25995079
[TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
6. [Cancer nanotherapy].
Kathmann W
Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S11-3. PubMed ID: 22438116
[No Abstract] [Full Text] [Related]
7. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
8. [Application and advancement of magnetic iron-oxide nanoparticles in tumor-targeted therapy].
Chen Y; Chen BA
Chin J Cancer; 2010 Jan; 29(1):125-8. PubMed ID: 20038325
[TBL] [Abstract][Full Text] [Related]
9. Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.
Hervault A; Thanh NT
Nanoscale; 2014 Oct; 6(20):11553-73. PubMed ID: 25212238
[TBL] [Abstract][Full Text] [Related]
10. Towards the use of nanoparticles in cancer therapy and imaging.
Pauwels EK; Erba P
Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of magnetic nanoparticles for hyperthermia.
Thiesen B; Jordan A
Int J Hyperthermia; 2008 Sep; 24(6):467-74. PubMed ID: 18608593
[TBL] [Abstract][Full Text] [Related]
12. Iron oxide magnetic nanoparticles as antimicrobials for therapeutics.
de Toledo LAS; Rosseto HC; Bruschi ML
Pharm Dev Technol; 2018 Apr; 23(4):316-323. PubMed ID: 28565928
[TBL] [Abstract][Full Text] [Related]
13. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
[TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
20. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
